• News
  • Pipeline
    • Reprofiling
    • Pipeline
  • Research
    • Zebrafish
    • Publications
  • Contact
    • Contact us
Menu
  • News
  • Pipeline
    • Reprofiling
    • Pipeline
  • Research
    • Zebrafish
    • Publications
  • Contact
    • Contact us

PRESS RELEASE

3Z closes $2 million funding for preclinical development of novel ADHD and Insomnia therapeutics identified by 3Z´s zebrafish drug discovery platform

Read More »
June 20, 2022